Potential role of non-antibiotics (helper compounds) in the treatment of multidrug-resistant Gram-negative infections: mechanisms for their direct and indirect activities.
about
Efflux-mediated drug resistance in bacteria: an updateRecent Advances in Multi-Drug Resistance (MDR) Efflux Pump Inhibitors of Gram-Positive Bacteria S. aureusA Mycobacterium tuberculosis sigma factor network responds to cell-envelope damage by the promising anti-mycobacterial thioridazineUV-light effects on cytochrome c modulated by the aggregation state of phenothiazinesFluorometric determination of ethidium bromide efflux kinetics in Escherichia coli.New Insights in to the Intrinsic and Acquired Drug Resistance Mechanisms in MycobacteriaIn vitro and in vivo activity of a novel sorafenib derivative SC5005 against MRSA.The Influence of Efflux Pump Inhibitors on the Activity of Non-Antibiotic NSAIDS against Gram-Negative Rods.Antibacterial & antitoxic effects of the cardiovascular drug lacidipine in an animal modelEvaluation of combination therapy for Burkholderia cenocepacia lung infection in different in vitro and in vivo models.Economics of antibiotic resistance.Efflux pump inhibitors: a strategy to combat P-glycoprotein and the NorA multidrug resistance pump.Strategies for bypassing the membrane barrier in multidrug resistant Gram-negative bacteria.Understanding efflux in Gram-negative bacteria: opportunities for drug discovery.Non-genetic mechanisms communicating antibiotic resistance: rethinking strategies for antimicrobial drug design.Inhibitors of mycobacterial efflux pumps as potential boosters for anti-tubercular drugs.A Simple Method for Assessment of MDR Bacteria for Over-Expressed Efflux Pumps.The intrinsic resistome of bacterial pathogens.Insight into synergetic mechanisms of tetracycline and the selective serotonin reuptake inhibitor, sertraline, in a tetracycline-resistant strain of Escherichia coli.Role of Phenothiazines and Structurally Similar Compounds of Plant Origin in the Fight against Infections by Drug Resistant Bacteria.Why and how thioridazine in combination with antibiotics to which the infective strain is resistant will cure totally drug-resistant tuberculosis.Recycling antibiotics into GUMBOS: a new combination strategy to combat multi-drug-resistant bacteria.Multidrug efflux pumps and their role in antibiotic and antiseptic resistance: a pharmacodynamic perspective.Antimicrobial Treatment of Polymeric Medical Devices by Silver Nanomaterials and Related Technology.New Roads Leading to Old Destinations: Efflux Pumps as Targets to Reverse Multidrug Resistance in Bacteria.Pimozide Inhibits the AcrAB-TolC Efflux Pump in Escherichia coli.Gallic acid-based indanone derivative interacts synergistically with tetracycline by inhibiting efflux pump in multidrug resistant E. coli.Synergy Potential of Indole Alkaloids and Its Derivative against Drug-resistant Escherichia coli.Random mutagenesis of the multidrug transporter AcrB from Escherichia coli for identification of putative target residues of efflux pump inhibitorsResveratrol induced inhibition of Escherichia coli proceeds via membrane oxidation and independent of diffusible reactive oxygen species generation.The Impact of Efflux Pump Inhibitors on the Activity of Selected Non-Antibiotic Medicinal Products against Gram-Negative Bacteria.Bacterial-Host Interactions: Physiology and Pathophysiology of Respiratory Infection.4-Hydroxy-α-tetralone and its derivative as drug resistance reversal agents in multi drug resistant Escherichia coli.In vitro synergistic effect of amlodipine and imipenem on the expression of the AdeABC efflux pump in multidrug-resistant Acinetobacter baumannii.Phytol Derivatives as Drug Resistance Reversal AgentsAntibacterial and Synergy of Clavine Alkaloid Lysergol and its Derivatives Against Nalidixic Acid-ResistantEscherichia coli
P2860
Q24609407-C1809529-75AA-4CAA-A90C-420F150987D6Q26829852-E120CA4F-299D-4AEE-ADC5-6423F8763BF5Q28473609-7CCC233E-CF5C-4BCA-9C68-04E61BCE5D21Q28534275-648D7B74-DAD2-4D32-81A4-79F5988F68CFQ33511013-0B6997F8-04F9-4742-A3D0-518B9ADE02D9Q33600161-B1D1047C-A902-482F-AA6C-5603456822F2Q35836858-268E69A9-01F0-4E36-A5AB-268491A98747Q35895154-DFB789EE-1637-4E68-9F79-5B97DD902DF9Q36134528-233B0E4E-2B49-40D4-AD35-45BE457A0B48Q36293970-549C3E65-B4FF-4E0F-AE01-C5FA6A99B870Q37228745-06D6C9C7-0265-4797-B907-F6B201EF8E11Q37725822-FD12420C-2A2C-4D44-B2B2-97DB10F65A6BQ37872942-95530ABA-A22E-4A7F-B88E-88D57DBF4668Q38011247-1C84DB2D-DD30-4F5E-81D2-164362E16391Q38031896-33B96911-539A-4A2A-AB49-085D4709A522Q38056146-784D33B7-1FBF-4914-812C-0964BB317006Q38099322-C9301E91-33A1-4115-B6E7-DDFD22FC9D2CQ38103861-F77F00FD-D507-49CC-886D-34F9CD53F8D3Q38683231-7093FDDA-7A46-4345-8304-CA758B559E8BQ38793887-D578814B-8A9D-4E88-B79F-5AA9B539A4A6Q38872081-31E9E2CF-A2C8-4A18-AB29-670BB3AAF847Q38888005-4742B179-3A01-474A-AB4E-11705F519F13Q38986360-EA8A99DF-0EEC-47E4-87D9-CE3D8CE7D115Q39140815-8666B9AC-4585-4BD6-80C9-469005ECE79EQ39179301-91A901A2-BCD7-4FCA-98F1-C33AA647C5CAQ39494097-9DDC2439-2B3F-4AD2-98A4-799CCCBA5A48Q40874282-9C916837-E160-4241-AF5E-E07DC11E00D5Q41129130-6540CEFA-C03A-4CDE-80B6-3D26A0292C7FQ41757269-906F2E0C-26AD-487B-B89E-B9E1B9336F8CQ41866653-226395DC-00FB-444B-94B9-FB6072F8A8CCQ46432988-466E68CD-7D59-46C2-97E2-C629F4230609Q52371735-865973CA-3881-4116-86F8-0407205C10A1Q54234724-24B8CF9E-D732-4790-9C80-2341C15BB181Q55262946-EC6138B8-CC69-48B1-B18B-AD5CAA843CDDQ57781152-31A326B4-360E-4C04-912D-0BA34305ED54Q57781155-6E4694F4-702F-487B-84E8-9291BA92213B
P2860
Potential role of non-antibiotics (helper compounds) in the treatment of multidrug-resistant Gram-negative infections: mechanisms for their direct and indirect activities.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Potential role of non-antibiot ...... irect and indirect activities.
@en
Potential role of non-antibiotics
@nl
type
label
Potential role of non-antibiot ...... irect and indirect activities.
@en
Potential role of non-antibiotics
@nl
prefLabel
Potential role of non-antibiot ...... irect and indirect activities.
@en
Potential role of non-antibiotics
@nl
P2093
P50
P921
P1476
Potential role of non-antibiot ...... irect and indirect activities.
@en
P2093
Jean-Marie Pagès
Jette E Kristiansen
Joseph Molnar
Sujata G Dastidar
Zsuzsanna Schelz
P304
P356
10.1016/J.IJANTIMICAG.2007.10.025
P577
2008-01-03T00:00:00Z